283 related articles for article (PubMed ID: 15878321)
21. 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity.
Roppe JR; Wang B; Huang D; Tehrani L; Kamenecka T; Schweiger EJ; Anderson JJ; Brodkin J; Jiang X; Cramer M; Chung J; Reyes-Manalo G; Munoz B; Cosford ND
Bioorg Med Chem Lett; 2004 Aug; 14(15):3993-6. PubMed ID: 15225713
[TBL] [Abstract][Full Text] [Related]
22. Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.
Bespalov AY; van Gaalen MM; Sukhotina IA; Wicke K; Mezler M; Schoemaker H; Gross G
Eur J Pharmacol; 2008 Sep; 592(1-3):96-102. PubMed ID: 18634781
[TBL] [Abstract][Full Text] [Related]
23. mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats.
Dravolina OA; Zakharova ES; Shekunova EV; Zvartau EE; Danysz W; Bespalov AY
Neuropharmacology; 2007 Feb; 52(2):263-9. PubMed ID: 16963088
[TBL] [Abstract][Full Text] [Related]
24. Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone.
Brodkin J; Busse C; Sukoff SJ; Varney MA
Pharmacol Biochem Behav; 2002 Sep; 73(2):359-66. PubMed ID: 12117590
[TBL] [Abstract][Full Text] [Related]
25. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice.
Kotlinska J; Bochenski M
Eur J Pharmacol; 2007 Mar; 558(1-3):113-8. PubMed ID: 17222405
[TBL] [Abstract][Full Text] [Related]
27. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
[TBL] [Abstract][Full Text] [Related]
28. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
29. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison.
Ballard TM; Woolley ML; Prinssen E; Huwyler J; Porter R; Spooren W
Psychopharmacology (Berl); 2005 Apr; 179(1):218-29. PubMed ID: 15739074
[TBL] [Abstract][Full Text] [Related]
30. Non-competitive metabotropic glutamate 1 receptor antagonists block activity of slowly adapting type I mechanoreceptor units in the rat sinus hair follicle.
Cahusac PM; Mavulati SC
Neuroscience; 2009 Oct; 163(3):933-41. PubMed ID: 19596050
[TBL] [Abstract][Full Text] [Related]
31. Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test.
Sevostianova N; Danysz W
Neuropharmacology; 2006 Sep; 51(3):623-30. PubMed ID: 16793067
[TBL] [Abstract][Full Text] [Related]
32. Functional interaction of NMDA and group I metabotropic glutamate receptors in negatively reinforced learning in rats.
Gravius A; Pietraszek M; Schmidt WJ; Danysz W
Psychopharmacology (Berl); 2006 Mar; 185(1):58-65. PubMed ID: 16402194
[TBL] [Abstract][Full Text] [Related]
33. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
Tatarczyńska E; Klodzińska A; Chojnacka-Wójcik E; Palucha A; Gasparini F; Kuhn R; Pilc A
Br J Pharmacol; 2001 Apr; 132(7):1423-30. PubMed ID: 11264235
[TBL] [Abstract][Full Text] [Related]
34. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
35. Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.
Porter RH; Jaeschke G; Spooren W; Ballard TM; Büttelmann B; Kolczewski S; Peters JU; Prinssen E; Wichmann J; Vieira E; Mühlemann A; Gatti S; Mutel V; Malherbe P
J Pharmacol Exp Ther; 2005 Nov; 315(2):711-21. PubMed ID: 16040814
[TBL] [Abstract][Full Text] [Related]
36. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.
Spooren WP; Vassout A; Neijt HC; Kuhn R; Gasparini F; Roux S; Porsolt RD; Gentsch C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1267-75. PubMed ID: 11082464
[TBL] [Abstract][Full Text] [Related]
37. Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats.
Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Pilc A
Pol J Pharmacol; 2000; 52(6):463-6. PubMed ID: 11334240
[TBL] [Abstract][Full Text] [Related]
38. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
[TBL] [Abstract][Full Text] [Related]
39. Estrus variation in anticonflict-like effects of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of female Wistar rats.
Molina-Hernández M; Tellez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo MT
Pharmacol Biochem Behav; 2006 Jul; 84(3):385-91. PubMed ID: 16793129
[TBL] [Abstract][Full Text] [Related]
40. Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test.
Steckler T; Lavreysen H; Oliveira AM; Aerts N; Van Craenendonck H; Prickaerts J; Megens A; Lesage AS
Psychopharmacology (Berl); 2005 Apr; 179(1):198-206. PubMed ID: 15821950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
